Cargando…

Feasibility of cabazitaxel in octogenarian prostate cancer patients

BACKGROUND: To evaluate the effectiveness and safety of cabazitaxel in castration-resistant prostate cancer patients aged ≥80 years, we performed a retrospective study on a sample of patients from 11 Italian cancer centers. MATERIALS AND METHODS: Fifty-seven patients aged ≥80 years were treated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tralongo, Paolo, Bordonaro, Sebastiano, Di Lorenzo, Giuseppe, De Giorgi, Ugo, Borsellino, Nicolò, Facchini, Gaetano, Rossetti, Sabrina, Fornarini, Giuseppe, Longo, Vito, Tralongo, Antonino Carmelo, Caspani, Francesca, Spada, Massimiliano, Calvani, Nicola, Carlini, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Special Topic - Advances in Prostate Cancer Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337820/ https://www.ncbi.nlm.nih.gov/pubmed/37448615 http://dx.doi.org/10.1097/CU9.0000000000000081

Ejemplares similares

Clinical and prostate multiparametric magnetic resonance imaging findings as predictors of general and clinically significant prostate cancer risk: A retrospective single-center study
por: Massanova, Matteo, et al.
Publicado: (2023)

Chemotherapy in frail elderly patients with hormone-refractory prostate cancer: A “real world” experience
por: Tralongo, Paolo, et al.
Publicado: (2016)

Re: Microwave focal therapy of prostate cancer: A non-clinical study and exploratory clinical trial
por: Tan, Wei Phin
Publicado: (2023)

Penile metastasis in prostate cancer patients: Two case reports, surgical excision technique, and literature review
por: Landen, Lucas, et al.
Publicado: (2023)

Learning curve for magnetic resonance imaging/ultrasound fusion prostate biopsy in detecting prostate cancer using cumulative sum analysis
por: Xu, Linhan, et al.
Publicado: (2023)

Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns()
por: Gebbia, Vittorio, et al.
Publicado: (2020)

Are the Number of Operations Appropriate to Define a High-Quality Breast Cancer Center?
por: Tralongo, Paolo, et al.
Publicado: (2023)

Metformin and Cancer Treatment
por: Di Mari, Annamaria, et al.
Publicado: (2015)

Cancer: New Needs, New Models. Is It Time for a Community Oncologist? Another Brick in the Wall
por: Tralongo, Paolo, et al.
Publicado: (2021)

Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer
por: Tralongo, Antonino Carmelo, et al.
Publicado: (2022)

Cancer patient-centered home care: a new model for health care in oncology
por: Tralongo, Paolo, et al.
Publicado: (2011)

Clinicians’ and Patients’ Perceptions and Use of the Word “Cured” in Cancer Care: An Italian Survey
por: Tralongo, Paolo, et al.
Publicado: (2023)

Prostate cancer screening: Continued controversies and novel biomarker advancements
por: Tidd-Johnson, Atiyah, et al.
Publicado: (2022)

Androgen receptor signaling–mitochondrial DNA–oxidative phosphorylation: A critical triangle in early prostate cancer
por: Sakellakis, Minas, et al.
Publicado: (2022)

Active home-based cancer treatment
por: Bordonaro, Sebastiano, et al.
Publicado: (2012)

Psychological and sexual disorders in long-term breast cancer survivors
por: Pumo, Vitalinda, et al.
Publicado: (2012)

Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience
por: Costa, Renato P., et al.
Publicado: (2019)

Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer
por: Avolio, Pier Paolo, et al.
Publicado: (2022)

Population‐based study of long‐term functional outcomes after prostate cancer treatment
por: Carlsson, Sigrid, et al.
Publicado: (2015)

An independent practice validation of the Prostate Imaging Reporting and Data System version 2 scoring system and the introduction of PDP (prostate-specific antigen density × PI-RADSv2) score to assist with further risk assessment
por: Patel, Parth U., et al.
Publicado: (2022)

Vitamin D receptor polymorphism and prostate cancer prognosis
por: El-attar, Ahmed Z., et al.
Publicado: (2022)

Determining the component-based operative time learning curve for robotic-assisted radical prostatectomy
por: Ambinder, David, et al.
Publicado: (2022)

Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

Single tertiary cancer center experience on the management of pT3b prostate cancer after robotic-assisted laparoscopic prostatectomy
por: Nayak, Arvind, et al.
Publicado: (2022)

Association between ABO blood group and unfavorable prostate cancer features after radical prostatectomy: Retrospective study of 1149 patients
por: Porcaro, Antonio Benito, et al.
Publicado: (2022)

Selecting lymph node–positive patients for adjuvant therapy after radical prostatectomy and extended pelvic lymphadenectomy: An outcome analysis of 100 node-positive patients managed without adjuvant therapy
por: Tamhankar, Ashwin Sunil, et al.
Publicado: (2022)

Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature
por: Cozzi, Salvatore, et al.
Publicado: (2022)

Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel
por: Gurioli, Giorgia, et al.
Publicado: (2022)

Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists
por: Blasi, Livio, et al.
Publicado: (2020)

Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments
por: Marra, Giancarlo, et al.
Publicado: (2022)

The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator
por: Parekh, Sneha, et al.
Publicado: (2022)

Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer
por: Godtman, Rebecka Arnsrud, et al.
Publicado: (2021)

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer
por: Ali Shah, Syed Imran
Publicado: (2015)

Prostate imaging and focal therapy
por: Connor, Martin J., et al.
Publicado: (2020)

The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer
por: Di Gianfrancesco, Luca, et al.
Publicado: (2022)

Acute kidney injury in a patient with metabolic syndrome
por: Li Cavoli, Gioacchino, et al.
Publicado: (2015)

Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly
por: Milinković, Ivan, et al.
Publicado: (2022)

Preclinical profile of cabazitaxel
por: Vrignaud, Patricia, et al.
Publicado: (2014)

Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment
por: Da Rosa, M.R., et al.
Publicado: (2011)

Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT)
por: Murray, Louise J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7ig3p7k8c0t5h0lu7lupqn3j3m